Reviva Pharmaceuticals clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Safety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaNCT05184335BrilaroxazineRecruiting2025-02Estimated

Phase 2 1 trial

TrialDrugs studiedStatusPrimary completion
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086RP5063, aripiprazoleCompleted2013-03Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.